Crizotinib is a targeted therapy drug used to treat ALK-positive or ROS1-positive non-small cell lung cancer (NSCLC), ALK-positive systemic anaplastic large cell lymphoma (ALCL) in children or younger adults.
Tag:
Crizotinib is a targeted therapy drug used to treat ALK-positive or ROS1-positive non-small cell lung cancer (NSCLC), ALK-positive systemic anaplastic large cell lymphoma (ALCL) in children or younger adults.
